Cite
HARVARD Citation
Lee, C. et al. (2021). Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysis. Cancer. 127 (14), pp. 2432-2441. [Online].